Assessing the impact of patient self‐selection on the costs to treat latent tuberculosis infection (LTBI) with isoniazid and transitional rifampin

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2753|20|5|685-691

ISSN: 1356-1294

Source: JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol.20, Iss.5, 2014-10, pp. : 685-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content